1. Home
  2. CNTB vs MTEN Comparison

CNTB vs MTEN Comparison

Compare CNTB & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • MTEN
  • Stock Information
  • Founded
  • CNTB 2012
  • MTEN 2015
  • Country
  • CNTB United States
  • MTEN China
  • Employees
  • CNTB N/A
  • MTEN N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • MTEN Building Products
  • Sector
  • CNTB Health Care
  • MTEN Industrials
  • Exchange
  • CNTB Nasdaq
  • MTEN Nasdaq
  • Market Cap
  • CNTB 54.4M
  • MTEN 64.3M
  • IPO Year
  • CNTB 2021
  • MTEN 2024
  • Fundamental
  • Price
  • CNTB $2.00
  • MTEN $14.30
  • Analyst Decision
  • CNTB Strong Buy
  • MTEN
  • Analyst Count
  • CNTB 2
  • MTEN 0
  • Target Price
  • CNTB $7.50
  • MTEN N/A
  • AVG Volume (30 Days)
  • CNTB 280.7K
  • MTEN 144.1K
  • Earning Date
  • CNTB 09-04-2025
  • MTEN 04-30-2025
  • Dividend Yield
  • CNTB N/A
  • MTEN N/A
  • EPS Growth
  • CNTB N/A
  • MTEN N/A
  • EPS
  • CNTB N/A
  • MTEN N/A
  • Revenue
  • CNTB $26,033,000.00
  • MTEN $10,120,257.00
  • Revenue This Year
  • CNTB N/A
  • MTEN N/A
  • Revenue Next Year
  • CNTB N/A
  • MTEN N/A
  • P/E Ratio
  • CNTB N/A
  • MTEN N/A
  • Revenue Growth
  • CNTB N/A
  • MTEN 23.03
  • 52 Week Low
  • CNTB $0.51
  • MTEN $3.20
  • 52 Week High
  • CNTB $2.86
  • MTEN $26.03
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 59.15
  • MTEN N/A
  • Support Level
  • CNTB $1.70
  • MTEN N/A
  • Resistance Level
  • CNTB $2.45
  • MTEN N/A
  • Average True Range (ATR)
  • CNTB 0.36
  • MTEN 0.00
  • MACD
  • CNTB -0.02
  • MTEN 0.00
  • Stochastic Oscillator
  • CNTB 42.51
  • MTEN 0.00

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About MTEN Mingteng International Corporation Inc. Ordinary Shares

Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.

Share on Social Networks: